Bdh Industries Ltd. | Small-cap | Healthcare
₹506.80
0.69%
| Bdh Industries Stock Comparison:
Bdh Industries vs Sun PharmaceuticalBdh Industries vs Divi's LaboratoriesBdh Industries vs Suven Life SciencesBdh Industries vs Sequent ScientificBdh Industries vs Aarti DrugsBdh Industries vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 186.2M
Gross Profit 48.8M 26.19%
Operating Income 19.0M 10.21%
Net Income 18.3M 9.81%
EPS (Diluted) ₹3.17

Balance Sheet Metrics

Total Assets 869.4M
Total Liabilities 181.8M
Shareholders Equity 687.6M
Debt to Equity 0.26

Cash Flow Metrics

Revenue & Profitability Trend

Bdh Industries Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i648.9M848.4M738.4M685.5M563.3M
Cost of Goods Sold i414.0M602.8M496.8M489.8M371.8M
Gross Profit i234.9M245.6M241.5M195.7M191.5M
Gross Margin % i36.2%29.0%32.7%28.6%34.0%
Operating Expenses
Research & Development i2.3M3.0M3.8M2.3M2.4M
Selling, General & Administrative i15.8M13.8M19.8M14.5M11.6M
Other Operating Expenses i42.0M39.7M44.5M29.8M40.4M
Total Operating Expenses i60.1M56.5M68.1M46.7M54.5M
Operating Income i107.0M118.5M103.8M84.5M77.2M
Operating Margin % i16.5%14.0%14.1%12.3%13.7%
Non-Operating Items
Interest Income i18.4M15.8M8.4M8.8M13.0M
Interest Expense i730.0K1.8M1.6M2.3M2.8M
Other Non-Operating Income-----
Pre-tax Income i124.7M132.5M110.7M95.5M87.5M
Income Tax i31.9M33.8M28.6M23.3M23.9M
Effective Tax Rate % i25.6%25.5%25.9%24.4%27.3%
Net Income i92.7M98.7M82.0M72.2M63.6M
Net Margin % i14.3%11.6%11.1%10.5%11.3%
Key Metrics
EBITDA i134.5M140.1M117.9M99.6M98.2M
EPS (Basic) i₹16.11₹17.14₹14.25₹12.55₹11.05
EPS (Diluted) i₹16.11₹17.14₹14.25₹12.55₹11.05
Basic Shares Outstanding i57562385757300575730057573005757300
Diluted Shares Outstanding i57562385757300575730057573005757300

Income Statement Trend

Bdh Industries Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i307.1M246.3M253.8M181.7M219.5M
Short-term Investments i-----
Accounts Receivable i141.8M283.6M166.4M145.2M151.8M
Inventory i73.9M50.0M71.6M67.1M54.3M
Other Current Assets10.0K10.0K10.0K17.0K16.0K
Total Current Assets i667.5M725.7M604.8M491.0M505.4M
Non-Current Assets
Property, Plant & Equipment i146.9M145.9M131.4M131.4M131.9M
Goodwill i-----
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets1.8M1.0K1.0K2.0M456.0K
Total Non-Current Assets i201.9M208.4M195.4M198.1M203.5M
Total Assets i869.4M934.1M800.3M689.1M709.0M
Liabilities
Current Liabilities
Accounts Payable i151.5M211.2M189.2M164.5M174.4M
Short-term Debt i9.8M86.9M48.5M22.5M85.1M
Current Portion of Long-term Debt-----
Other Current Liabilities728.0K728.0K928.0K728.0K817.0K
Total Current Liabilities i169.2M306.6M246.1M195.9M269.5M
Non-Current Liabilities
Long-term Debt i-----
Deferred Tax Liabilities i10.6M4.4M360.0K466.0K349.0K
Other Non-Current Liabilities--5.5M5.5M5.5M
Total Non-Current Liabilities i12.6M6.0M7.2M7.4M8.8M
Total Liabilities i181.8M312.5M253.3M203.3M278.3M
Equity
Common Stock i57.6M57.6M57.6M57.6M59.4M
Retained Earnings i457.6M405.5M345.4M296.5M252.0M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i687.6M621.6M546.9M485.9M430.7M
Key Metrics
Total Debt i9.8M86.9M48.5M22.5M85.1M
Working Capital i498.3M419.1M358.7M295.2M235.9M

Balance Sheet Composition

Bdh Industries Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i124.7M132.5M110.7M95.5M87.5M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i121.9M-126.1M-43.9M-20.6M-72.0M
Operating Cash Flow i227.9M-9.0M59.8M64.4M4.2M
Investing Activities
Capital Expenditures i-2.1M-18.9M-42.0K5.0M-146.0K
Acquisitions i-----
Investment Purchases i00-3.5M0-
Investment Sales i-----
Investing Cash Flow i-2.1M-18.9M-3.5M5.0M-146.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i-25.9M-23.0M-20.7M-17.3M-14.4M
Debt Issuance i-----
Debt Repayment i-77.1M---62.6M-7.2M
Financing Cash Flow i-180.1M15.4M5.2M-142.4M-28.7M
Free Cash Flow i145.6M-37.6M62.9M28.0M7.7M
Net Change in Cash i45.6M-12.5M61.5M-73.0M-24.6M

Cash Flow Trend

Bdh Industries Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 27.48
Forward P/E 69.91
Price to Book 4.21
Price to Sales 4.21
PEG Ratio 1.66

Profitability Ratios

Profit Margin 13.84%
Operating Margin 10.21%
Return on Equity 13.49%
Return on Assets 10.67%

Financial Health

Current Ratio 3.95
Debt to Equity 1.43
Beta 0.20

Per Share Data

EPS (TTM) ₹18.32
Book Value per Share ₹119.43
Revenue per Share ₹119.65

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
bdh3.0B27.484.2113.49%13.84%1.43
Sun Pharmaceutical 3.9T36.745.3015.08%19.29%3.26
Divi's Laboratories 1.6T65.3610.0914.64%23.89%0.03
Suven Life Sciences 48.2B-28.0140.49-146.15%84.44%0.00
Sequent Scientific 48.1B166.336.612.84%1.85%62.47
Aarti Drugs 44.5B23.663.2612.28%7.80%44.92

Financial data is updated regularly. All figures are in the company's reporting currency.